Results
1 -
10 of
96The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus, Cardiovascular Diabetology Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits, Diabetologia SGLT2 Inhibitors for Treating Diabetes, Essentials of SGLT2 Inhibitors in Diabetes Using SGLT2 Inhibitors in Special Populations, Essentials of SGLT2 Inhibitors in Diabetes Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials, Diabetologia A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans, Naunyn-Schmiedeberg's Archives of Pharmacology Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation, Diabetologia The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes, Diabetologia The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE ???/??? mice fed a western diet, Diabetologia